Target intelligence / Profile preview

Cellular membrane lipid raft

Molecular classification
Membrane microdomain, Lipid-protein assembly, Other
01

Overview

Cellular membrane lipid rafts are small (10–200 nm), heterogeneous, and highly dynamic microdomains within the plasma membrane that are enriched in cholesterol, sphingolipids, and specific proteins like glycosylphosphatidylinositol (GPI)-anchored proteins (Pike, 2006). These domains act as specialized platforms that compartmentalize cellular processes, facilitating signal transduction, protein sorting, and membrane trafficking by concentrating or segregating signaling molecules (Simons & Toomre, 2000). In pathological contexts, lipid rafts are frequently exploited by pathogens, such as HIV-1 and SARS-CoV-2, for cellular entry and budding, and they serve as critical sites for the accumulation of proteins involved in neurodegenerative diseases like Alzheimer's (Michel & Bakovic, 2007). In oncology, lipid rafts facilitate the assembly of pro-survival signaling complexes, such as those involving Akt and EGFR, making them attractive targets for anti-cancer therapies (Mollinedo & Gajate, 2015). Therapeutic intervention typically involves the use of agents that deplete cholesterol or sequester lipids to disrupt raft integrity, thereby modulating downstream signaling or blocking infection.

Other names
Lipid raftMembrane microdomainDetergent-resistant membraneDRMCholesterol-rich domain
02

Mechanism of action

Pharmacological modulation of lipid rafts primarily involves the depletion or sequestration of cholesterol, which disrupts the structural integrity of these domains and subsequently inhibits the assembly of raft-associated signaling complexes or prevents the entry of pathogens (Simons & Toomre, 2000; Mollinedo & Gajate, 2015).

03

Biological functions

Signal transductionProtein traffickingEndocytosisCell adhesionViral entry and budding
04

Disease associations

CancerNeurodegenerative diseaseInfectionCardiovascular diseasePrion disease
05

Safety considerations

Non-specific membrane disruptionSystemic cholesterol depletion side effectsInterference with essential physiological signalingPotential for cytotoxicity
06

Interacting drugs

Methyl-beta-cyclodextrin

7 more in the full profile.

07

Biomarkers

Caveolin-1Flotillin-1GM1 gangliosideGPI-anchored proteins

Beyond the preview

Go deeper on Cellular membrane lipid raft.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellular membrane lipid raft.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call